CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Patients With Food Allergies Rank Top Dining-Out Safeguards

Published: Sat, 17 Nov 2018 11:31:27 EST
People who use more preventive strategies when eating out at a restaurant reduce the risk for a reaction, new research shows.
Medscape Medical News

Can Patient-Generated Data Help Regulate Medical Devices?

Published: Fri, 16 Nov 2018 17:43:56 EST
An FDA panel discussed ways the agency can use patient-driven platforms -- including social media, digital health technology, and patient registry data -- to assist with regulatory evaluation of medical devices.
Medscape Medical News
Displaying results 19-20 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Roivant raises $200M, at $7B valuation, to add to startup roster

Published: Tue, 13 Nov 2018 13:50:50 +0000
Roivant Sciences has raised $200 million to roll out another round of startups. The financing, which comes 15 months after Roivant raised $1.1 billion, is tied to a $7 billion valuation for the fast-growing biotech umbrella organization.

Mesoblast defends stem cell therapy for heart failure after trial miss

Published: Tue, 13 Nov 2018 13:47:51 +0000
Mesoblast’s stem cell-based therapy was unable to reduce heart failure patients’ reliance on a left ventricular assist device in a phase 2 trial, sparking a steep slide in its shares.

Fresh from Eli Lilly deal, NextCure bags $93M for clinical push

Published: Tue, 13 Nov 2018 13:11:48 +0000
NextCure has raised $93 million. The Eli Lilly-partnered biotech will use the series B funds to advance Siglec-15-targeting antibody NC318 and another asset through early-phase clinical development.
Displaying results 19-21 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top